India In Vitro Diagnostics Market to grow with a CAGR of 5.45% through 2030
Increasing healthcare
infrastructure and a supportive regulatory environment are expected to drive
the India In Vitro Diagnostics Market growth in the forecast period, 2026-2030
According to TechSci Research report, “India
In Vitro Diagnostics Market – By Region, Competition, Forecast & Opportunities, 2030F”, India In Vitro Diagnostics
Market stood at USD 1.74 billion in 2024 and is anticipated to grow with a CAGR of 5.45% in the forecast period, 2026-2030. This can be due to collaborations and partnerships among leading companies with
a diverse approach to merge the expertise of individual companies and to
strengthen their position in the market.
Increasing healthcare awareness indeed plays a
vital role in driving the demand for In Vitro Diagnostics (IVD). Greater
healthcare awareness leads to more proactive health-seeking behavior. People
are more likely to seek diagnostic tests and screenings for early disease
detection, especially for conditions like cancer, diabetes, and heart disease.
Healthcare awareness encourages individuals to adopt preventive healthcare
measures, including regular check-ups and diagnostic testing. Preventive
healthcare aims to identify health issues before they become serious, and IVD
tests are instrumental in this regard. Healthcare awareness campaigns often
include health screening programs and events. These programs offer accessible
diagnostic tests to the community, raising awareness about the importance of
regular health check-ups. Awareness about vaccinations and immunization
schedules is crucial for public health. IVD tests, such as serological assays,
help determine an individual's immunity to specific diseases and the need for
vaccination.
Browse over XX market data
Figures and spread through XX Pages and an
in-depth TOC on " India In Vitro Diagnostics Market”
India In Vitro Diagnostics Market is segmented
based on product, test type, usability, end-user, application, and by region.
Based on End User, the hospitals & clinics segment is anticipated to demonstrate the fastest growth in the India In Vitro Diagnostics Market through 2030. Hospitals and clinics typically
have a high volume of patients seeking healthcare services. They serve as
primary points of contact for patients, making them significant consumers of
diagnostic services. This high patient footfall naturally drives the demand for
IVD tests. Hospitals and clinics offer comprehensive healthcare services,
including diagnostic testing. Patients visit these facilities not only for
diagnostics but also for treatment and management of various medical
conditions. IVD tests are an integral part of the diagnostic and treatment
process. Many hospitals, particularly larger ones, offer specialized care such
as cardiac care, oncology, neurology, and more. Specialized healthcare often requires a wide range
of diagnostic tests to diagnose and monitor patients, further boosting the
demand for IVD products. Hospitals are equipped to handle emergency and
critical care cases. In such situations, rapid and accurate diagnostic tests
are essential for making immediate treatment decisions. IVD tests play a
critical role in emergency and critical care settings. Hospitals often have
in-house pathology labs for conducting a variety of tests, including blood
tests, urine tests, and tissue biopsies. These labs are major consumers of IVD
products. After the diagnosis, patients visit hospitals and clinics for
follow-up appointments and treatment monitoring. IVD tests are routinely used
to assess the progress of treatment and make necessary adjustments.
Based on Region, North India is anticipated to demonstrate the fastest growth in the India In Vitro Diagnostics Market through 2030. There is a relatively higher level of health awareness and education among the population in North India. This can lead to greater demand for diagnostic services and early disease detection. The North Indian states have been witnessing significant urbanization, which often goes hand in hand with increased healthcare access and demand for diagnostics. Delhi and nearby areas have established themselves as hubs for medical tourism, attracting patients from other countries. This boosts the demand for high-quality diagnostic services and medical tests. The North has a burgeoning pharmaceutical and biotechnology industry, which relies heavily on diagnostics for research, development, and quality control. The well-developed transport and connectivity infrastructure in North India ensures the efficient distribution and transportation of diagnostic equipment and products.
Some of the major companies
operating in the India In Vitro Diagnostics Market include:
- Abbott India Limited
- Danaher (DHR) Holding India Pvt Limited
- Roche Diagnostics India Pvt. Ltd.
- bioMérieux India Private Limited
- Transasia Bio-Medicals Ltd.
- bioMérieux India Limited
- Becton Dickinson Private Limited
- Thermo Fisher Scientific India Pvt. Ltd.
- Siemens Healthcare Private Limited
- Sysmex India Pvt. Ltd
Download Free Sample Report
Customers can also request for
10% free customization on this report
“With a burgeoning middle class and expanding
healthcare infrastructure, there's a shift towards preventive healthcare,
boosting demand for diagnostics. Innovative solutions like point-of-care
testing and molecular diagnostics are gaining traction, enabling quicker and
more accurate disease detection. Government initiatives to enhance healthcare
accessibility and affordability will further propel market expansion.
Collaboration between local and international players will foster expertise interchange,
driving the development of tailored diagnostic solutions for India's diverse
healthcare landscape", said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.
"India In Vitro Diagnostics Market By Product (Instrument, Reagent, Other Products), By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other Types), By Usability (Disposable In Vitro Diagnostics Devices, Reusable In Vitro Diagnostics Devices), By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, Others), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), By Region, Competition, Forecast and Opportunities, 2020-2030F" has evaluated
the future growth potential of India In Vitro Diagnostics Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India In Vitro Diagnostics Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com